A Study of the Transition From Cangrelor to Clopidogrel or Prasugrel in Patients With Coronary Artery Disease.

Trial Profile

A Study of the Transition From Cangrelor to Clopidogrel or Prasugrel in Patients With Coronary Artery Disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Mar 2015

At a glance

  • Drugs Cangrelor (Primary) ; Clopidogrel; Prasugrel
  • Indications Coronary artery disease
  • Focus Pharmacodynamics
  • Sponsors Medicines Company
  • Most Recent Events

    • 26 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 28 Jan 2014 Planned End Date changed from 1 Dec 2013 to 1 Jan 2014 as reported by ClinialTrials.gov
    • 28 Jan 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top